Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Deals

Takeda pursuing exosome therapies through Evox deal

Elizabeth S. Eaton, Staff Writer
March 27, 2020 12:58 AM UTC

Takeda is betting on Evox’s exosome drug delivery technology via a partnership to develop five protein replacement and mRNA therapies for rare diseases.

Evox Therapeutics Ltd., an Oxford, U.K.-based biotech, is eligible to receive up to $882 million in payments, including $44 million in an upfront payment, near-term milestones and research funding, plus tiered royalties. ...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Evox Therapeutics Ltd.

Takeda Pharmaceutical Co. Ltd.